Metin Kurtoglu - Jan 3, 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Chief Technology Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Metin Kurtoglu
Stock symbol
RNAC
Transactions as of
Jan 3, 2025
Transactions value $
-$81,790
Form type
4
Date filed
1/7/2025, 08:05 PM
Previous filing
Jan 6, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Sale -$40.4K -2.42K -3.6% $16.72 64.7K Jan 3, 2025 Direct F1
transaction RNAC Common Stock Sale -$41.4K -2.46K -3.8% $16.83 62.3K Jan 6, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.